Effect of Paullinia cupana on MCF‑7 breast cancer cell response to chemotherapeutic drugs

Hertz,Everaldo; Cadoná,Francine  Carla; Machado,Alencar  Kolinski; Azzolin,Verônica; Holmrich,Sabrina; Assmann,Charles; Ledur,Pauline; Ribeiro,Euler  Esteves; de Souza Filho,Olmiro   Cezimbra; Mânica‑Cattani,Maria   Fernanda; da Cruz,Ivana  Beatrice Mânica

doi:10.3892/mco.2014.438

Effect of Paullinia cupana on MCF‑7 breast cancer cell response to chemotherapeutic drugs

Authors:
- Everaldo Hertz
- Francine Carla Cadoná
- Alencar Kolinski Machado
- Verônica Azzolin
- Sabrina Holmrich
- Charles Assmann
- Pauline Ledur
- Euler Esteves Ribeiro
- Olmiro Cezimbra de Souza Filho
- Maria Fernanda Mânica‑Cattani
- Ivana Beatrice Mânica da Cruz
View Affiliations

Affiliations: Postgraduate Program in Pharmacology, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul 97105‑900, Brazil, Postgraduate Program in Biochemistry and Toxicology, Center of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul 97105‑900, Brazil, Laboratory of Biogenomics, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul 97105‑900, Brazil, Open University of the Third Age, State University of Amazonas, Manaus, Amazonas 69050-900, Brazil
Published online on: October 8, 2014 https://doi.org/10.3892/mco.2014.438
Pages: 37-43

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies suggested that certain plants, such as guarana (Paullinia cupana), exert a protective effect against cancer‑related fatigue in breast cancer patients undergoing chemotherapy. However, guarana possesses bioactive molecules, such as caffeine and catechin, which may affect the pharmacological properties of antitumor drugs. Therefore, the aim of this study was to evaluate the effects of guarana on breast cancer cell response to 7 chemotherapeutic agents currently used in the treatment of breast cancer. To perform this study, MCF‑7 breast cancer cells were cultured under controlled conditions and exposed to 1, 5 and 10 µg/ml guarana concentrations, with and without chemotherapeutics (gemcitabine, vinorelbine, methotrexate, 5‑fluorouracil, paclitaxel, doxorubicin and cyclophosphamide). The effect of these treatments on MCF‑7 cell viability and proliferation was spectrophotometrically analyzed with the MTT assay. The main results demonstrated an antiproliferative effect of guarana at concentrations of 5 and 10 µg/ml and a significant effect on chemotherapeutic drug action. In general, guarana improved the antiproliferative effect of chemotherapeutic agents, causing a decrease of >40% in cell growth after 72 h of exposure. The results suggested an interaction of guarana with the chemotherapeutic drugs, which requires confirmation by in vivo complementary studies.

View Figures

View References

1	Weiss J: Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res. 11:441–446. 2011. View Article : Google Scholar : PubMed/NCBI
2	Byar KL, Berger AM, Bakken SL, et al: Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 33:E18–E26. 2006. View Article : Google Scholar : PubMed/NCBI
3	de Jong N, Courtens AM, Abu-Saad HH, et al: Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs. 25:283–297. 2002.
4	Saligan LN and Kim HS: A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun. 26:830–848. 2012. View Article : Google Scholar : PubMed/NCBI
5	Campos MP, Hassan BJ, Riechelmann R and Del Giglio A: Cancer-related fatigue: a review. Rev Assoc Med Bras. 57:211–219. 2011.
6	de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB and Del Giglio A: Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J Altern Complement Med. 17:505–512. 2011.
7	Schimpl FC, da Silva JF, Gonçalves JF and Mazzafera P: Guaraná: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol. 150:14–31. 2013.
8	del Giglio AB, Cubero Dde I, Lerner TG, Guariento RT, de Azevedo RG, Paiva H, Goldman C, Carelli B, Cruz FM, Schindler F, Pianowski L, de Matos LL and del Giglio A: Purified dry extract of Paullinia cupana (guaraná) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: an early discontinuation study. J Diet Suppl. 10:325–334. 2013.
9	Basile A, Ferrara L, Pezzo MD, Mele G, Sorbo S, Bassi P and Montesano D: Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana Mart. J Ethnopharmacol. 102:32–36. 2005. View Article : Google Scholar : PubMed/NCBI
10	Valcic S, Timmermann BN, Alberts DS, Wächter GA, Krutzsch M, Wymer J and Guillén JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996. View Article : Google Scholar : PubMed/NCBI
11	Wu AH and Butler LM: Green tea and breast cancer. Mol Nutr Food Res. 55:921–930. 2011. View Article : Google Scholar : PubMed/NCBI
12	Jiang W, Wu Y and Jiang X: Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol. 129:620–629. 2013. View Article : Google Scholar : PubMed/NCBI
13	Hill GM, Moriarity DM and Setzer WN: Attenuation of cytotoxic natural product DNA intercalating agents by caffeine. Sci Pharm. 79:729–747. 2011. View Article : Google Scholar : PubMed/NCBI
14	Saunders DE, Lawrence WD, Christensen C, Wappler NL, Ruan H and Deppe G: Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int J Cancer. 70:214–220. 1997. View Article : Google Scholar : PubMed/NCBI
15	Martins IL, Miranda JP, Oliveira NG, Fernandes AS, Gonçalves S and Antunes AM: Synthesis and biological activity of 6-selenocaffeine: potential modulator of chemotherapeutic drugs in breast cancer cells. Molecules. 18:5251–5264. 2013. View Article : Google Scholar : PubMed/NCBI
16	Bittencourt LS, Machado DC, Machado MM, et al: The protective effects of guaraná extract (Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprusside. Food Chem Toxicol. 53:119–125. 2013.
17	Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
18	Trebunova M, Laputkova G, Slaba E, Lacjakova K and Verebova A: Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7. Anticancer Res. 32:2849–2854. 2012.PubMed/NCBI
19	Major PP, Egan EM, Sargent L and Kufe DW: Modulation of 5-FU metabolism in human MCF-7 breast carcinoma cells. Cancer Chemother Pharmacol. 8:87–91. 1982. View Article : Google Scholar : PubMed/NCBI
20	Matsuoka H, Furusawa M, Tomoda H and Seo Y: Difference in cytotoxicity of paclitaxel against neoplastic and normal cells. Anticancer Res. 14:163–167. 1994.PubMed/NCBI
21	Sugiyama K, Shimizu M, Akiyama T, Ishida H, Okabe M, Tamaoki T and Akinaga S: Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro. Br J Cancer. 77:1737–1743. 1998. View Article : Google Scholar : PubMed/NCBI
22	Zeybek ND, Inan S, Ekerbicer N, Vatansever HS, Karakaya J and Muftuoglu SF: The effects of gemcitabine and vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells. Acta Histochem. 113:62–67. 2011. View Article : Google Scholar : PubMed/NCBI
23	Barros S, Mencia N, Rodríguez L, Oleaga C, Santos C, Noé V and Ciudad CJ: The redox state of cytochrome c modulates resistance to methotrexate in human MCF7 breast cancer cells. PLoS One. 8:e632762013.PubMed/NCBI
24	Hattangadi DK, DeMasters GA, Walker TD, Jones KR, Di X, Newsham IF and Gewirtz DA: Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem Pharmacol. 68:1699–1708. 2004. View Article : Google Scholar : PubMed/NCBI
25	Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ and Harris AL: Increased sensitivity to the prodrug 5′;-deoxy-5-fluorouridine and modulation of 5-fluoro-2′;-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer. 72:669–675. 1995.
26	Fukui M, Yamabe N and Zhu BT: Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer. 46:1882–1891. 2010. View Article : Google Scholar : PubMed/NCBI
27	Singh N, Nigam M, Ranjan V, et al: Resveratrol as an adjunct therapy in cyclophosphamide-treated MCF-7 cells and breast tumor explants. Cancer Sci. 102:1059–1067. 2011. View Article : Google Scholar : PubMed/NCBI
28	Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.PubMed/NCBI
29	Campos AR, Barros AI, Santos FA and Rao VS: Guaraná (Paullinia cupana Mart.) offers protection against gastric lesions induced by ethanol and indomethacin in rats. Phytother Res. 17:1199–1202. 2003.
30	Otobone FJ, Sanches AC, Nagae R, Martins JV, Sela VR, de Mello JC and Audi EA: Effect of lyophilized extracts from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on behavioral profiles in rats. Phytother Res. 21:531–535. 2007.
31	Roncon CM, Biesdorf de Almeida C, Klein T, de Mello JC and Audi EA: Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test. Planta Med. 77:236–241. 2011.PubMed/NCBI
32	Fukumasu H, Latorre AO and Zaidan-Dagli ML: Paullinia cupana Mart. var. sorbilis, guarana, increases survival of Ehrlich ascites carcinoma (EAC) bearing mice by decreasing cyclin-D1 expression and inducing a G0/G1 cell cycle arrest in EAC cells. Phytother Res. 25:11–16. 2011. View Article : Google Scholar
33	Fukumasu H, Avanzo JL, Nagamine MK, Barbuto JA, Rao KV and Dagli ML: Paullinia cupana Mart var. sorbilis, guaraná, reduces cell proliferation and increases apoptosis of B16/F10 melanoma lung metastases in mice. Braz J Med Biol Res. 41:305–310. 2008. View Article : Google Scholar
34	Fukumasu H, da Silva TC, Avanzo JL, et al: Chemopreventive effects of Paullinia cupana Mart var. sorbilis, the guaraná, on mouse hepatocarcinogenesis. Cancer Lett. 233:158–164. 2006.
35	Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL and Assaraf YG: Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem. 279:25527–25534. 2004. View Article : Google Scholar
36	Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB and Dezube B: Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res. 11:1555–1560. 1991.PubMed/NCBI
37	Ding R, Shi J, Pabon K and Scotto KW: Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance. Mol Pharmacol. 81:328–337. 2012. View Article : Google Scholar : PubMed/NCBI
38	Seeram NP, Zhang Y and Nair MG: Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr Cancer. 46:101–106. 2003. View Article : Google Scholar : PubMed/NCBI
39	Alshatwi AA: Catechin hydrate suppresses MCF-7 proliferation through TP53/caspase-mediated apoptosis. J Exp Clin Cancer Res. 29(167)2010. View Article : Google Scholar : PubMed/NCBI
40	Farabegoli F, Papi A, Bartolini G, Ostan R and Orlandi M: (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. 17:356–362. 2010. View Article : Google Scholar : PubMed/NCBI
41	Fix LN, Shah M, Efferth T, Farwell MA and Zhang B: MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics. 7:261–277. 2010.PubMed/NCBI